The headline figure is striking: for the first time in the history of the survey, every cardiology subspecialty reported its highest median total compensation ever recorded by MedAxiom. Overall median cardiology compensation climbed nearly 5 percent to $727,712, a figure that reflects both the intensifying competition for trained cardiologists and the growing financial pressure on programs to retain the clinicians they already have. Cardiac surgery delivered the single most remarkable data point of the year, with median total compensation exceeding $1 million, the first time any cardiovascular specialty has crossed that threshold since the report began.

Compensation, however, is only half of the story. The survey shows that productivity rose broadly across the specialty, with every cardiology subspecialty reporting higher median work relative value unit production in 2025. The wRVU, or work relative value unit, is the standard metric used across American medicine to quantify physician work effort, assigning a standardized value to each service a clinician performs regardless of geography or payer. Advanced heart failure programs posted the largest year-over-year productivity gain at nearly 11 percent, a signal of how hard teams caring for the sickest patients are being pushed to expand access.

Behind the productivity gains sits an even more consequential trend: patient volumes have reached unprecedented levels. Median new patient volumes and median patient panel size both hit record highs in 2025, with patient panel and total new patient visits each increasing 18 percent over the past five years. The median cardiologist now manages a panel of more than 2,000 patients, a workload that illustrates the scale of the demographic and epidemiological forces bearing down on cardiovascular care. As the population ages and the prevalence of cardiovascular risk factors such as hypertension, obesity and diabetes continues to climb, the demand for specialist attention has outstripped the supply of trained physicians for years, and the new data quantify just how far that gap has widened.

Programs are responding to that scarcity in ways that are reshaping the structure of cardiovascular care teams. The most significant of these responses is the expanded deployment of advanced practice providers, the nurse practitioners and physician assistants who increasingly deliver frontline cardiovascular care. Cardiology APP productivity reached a new benchmark in 2025, exceeding 2,000 median annual wRVUs for the first time in survey history, an increase of approximately 30 percent since 2021. That trajectory suggests that APPs are no longer simply supplementing physician capacity; they have become a structural pillar of cardiovascular service delivery, absorbing a growing share of patient visits, follow-up care and chronic disease management.

Jerry Blackwell, MD, MBA, FACC, president and CEO of MedAxiom, framed the findings as a portrait of a workforce under sustained strain. According to Blackwell, this year’s data show a cardiovascular workforce under increasing pressure to meet growing patient demand, with programs responding through higher productivity, expanded APP utilization and evolving compensation models. He noted that these trends offer important insight into how leading organizations are adapting to today’s challenges while preparing for future growth. The statement captures the central tension of the report: the same forces that are driving compensation upward are the ones that make every hire more valuable and every departure more costly.

The 2026 edition also introduces a methodological change that will matter to anyone who uses the report for benchmarking. For the first time in the survey’s history, academic medical center compensation and production data are reported separately in both the cardiology and APP sections. The separation acknowledges a long-standing frustration in workforce analytics: academic centers operate under fundamentally different missions, payer mixes and clinical structures than community programs, and blending their data has historically obscured meaningful differences. By isolating academic data, MedAxiom has made the benchmarks considerably more actionable for the two distinct worlds of American cardiovascular medicine.

Two clinical domains stand out in the volume data as engines of growth. Advanced cardiac imaging continues to expand at a remarkable pace, with median advanced imaging volumes per patient panel increasing 36 percent from 2024 to 2025, and the ratio of advanced imaging studies to cardiac catheterizations now exceeding 50 percent. This shift reflects both technological maturation and clinical strategy: as computed tomography angiography, cardiac magnetic resonance and advanced echocardiography become more capable and more widely available, they are increasingly displacing or complementing invasive catheterization in diagnostic pathways. Meanwhile, electrophysiology volumes are accelerating even faster, with median ablations per EP physician increasing more than 140 percent over five years, a surge driven by the rising prevalence of atrial fibrillation and by the expanding armamentarium of catheter-based therapies, including pulsed field ablation, that have broadened the population of patients eligible for intervention.

For healthcare leaders, the practical implications of the report are direct. The survey is powered by MedAxcess, MedAxiom’s proprietary cardiovascular business intelligence platform, and it provides benchmarks spanning physician and APP compensation, productivity, staffing, patient access and workforce planning. Unlike broad healthcare compensation surveys that aggregate data across specialties, the report focuses exclusively on cardiovascular care and the operational challenges specific to cardiovascular programs, which makes it one of the most comprehensive cardiovascular-specific benchmarking resources available. Administrators can use it to evaluate provider performance against national peers, calibrate compensation models in a seller’s market for talent, and design staffing strategies that balance physicians and APPs in ways that preserve both access and quality.

Taken together, the 2026 findings describe a cardiovascular industry adapting in real time to sustained growth in patient demand through rising productivity, expanding APP utilization and evolving compensation strategies. The record figures are not simply a story about physician earnings; they are a signal of scarcity, of shifting care-team architecture and of the financial stakes involved in keeping cardiovascular programs viable. As demand continues to grow and the pipeline of newly trained cardiologists remains constrained, the trends documented in this survey are likely to intensify, and the organizations that read them clearly, the report suggests, will be the ones best positioned to meet the cardiovascular needs of the decade ahead.

Subject of Research: National benchmarking of cardiovascular physician and advanced practice provider compensation and productivity

Article Title: MedAxiom releases 2026 Cardiovascular Provider Compensation & Production Survey Report, revealing record compensation, rising productivity and growing workforce demands

Article References: MedAxiom releases 2026 Cardiovascular Provider Compensation & Production Survey Report, revealing record compensation, rising productivity and growing workforce demands. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: cardiology, MedAxiom, physician compensation, advanced practice providers, wRVU productivity, cardiac surgery, electrophysiology, advanced imaging, workforce shortages, healthcare benchmarking, patient demand, cardiovascular medicine

The difficulty in understanding and controlling the conversion of lithium polysulfides (LiPSs) during battery cycling stems largely from the dynamic and highly concentrated nature of reactant distributions at the electrode–electrolyte interface. In these environments, the balance between surface-bound and dissolved species dictates the overall electrochemical performance. The new research deploys advanced in situ liquid-cell electron microscopy techniques to directly visualize these sophisticated concentration gradients, a feat that has eluded scientists due to the liquid phase’s complexity and the scales involved.

What emerges from this study is a revelation of concentration-driven phase segregation phenomena right at the interfacial layers, termed high-concentration interfacial layers (HCILs). These HCILs form as LiPSs aggregate in the immediate vicinity of the electrode surface during cycling, dramatically altering the local reaction environment. This segregation is not merely a passive occurrence; it actively directs charge-transfer dynamics by establishing competitive conditions between surface-mediated and solution-based pathways. The delicate interplay in these zones influences where and how lithium sulfide (Li₂S) nucleates and grows, directly impacting the battery’s capacity retention and cycling stability.

Complementing the microscopy observations, computational explorations using density functional theory (DFT) provide a molecular-level understanding of how LiPS clusters modify their electronic structure upon aggregation. The study identifies that the molecular geometries and orbital hybridizations evolve as LiPSs coalesce, resulting in enhanced electronic interactions that facilitate charge transfer through the concentrated clusters. This phenomenon fundamentally challenges previously held models which treated LiPS species largely as isolated entities, offering a new paradigm that accounts for collective behavior in highly concentrated solutions.

The practical implications of these mechanistic insights are far-reaching. By comprehending how HCILs govern interfacial reaction pathways, the researchers have engineered electrodes that strategically balance surface and solution reactions amidst high LiPS concentrations. These meticulously optimized electrodes enable impressive fast-charging capabilities—reaching rates up to 4 C with current densities of 26.8 mA cm⁻²—without compromising energy density, which itself surges beyond 400 Wh kg⁻¹. Such milestones represent a substantial leap forward in the achievable performance metrics for Li–S battery technology.

This study’s significance extends beyond the immediate Li–S chemistry, addressing a broader challenge in electrochemical energy conversion: capturing and controlling complex interfacial phenomena under dynamically varying concentrations. The in situ liquid-cell electron microscopy method establishes a powerful approach for observing reactive species and phase evolution directly in their native electrochemical environment. As such, it holds promise to transform research across a host of energy storage and catalysis systems where interfacial reactions dictate overall function.

Notably, this work also clarifies why lean electrolyte conditions—essential for practical high-energy devices—have historically been so difficult to optimize. The rich detail uncovered concerning phase segregation and charge transfer competition suggests that managing HCIL formation and stability may be the key to unlocking robust Li₂S deposition and dissolution cycles. Hence, this strategy could mitigate common pitfalls like cathode passivation and capacity fading, which have limited long-term operational viability.

The fusion of experimental visualization with robust theoretical modeling provides a comprehensive framework that future researchers and engineers can exploit to rationally design electrode interfaces. Moving past empirical trial-and-error, the ability to predict and control molecular aggregation behavior and its effects on electronic properties opens new avenues for tuning battery chemistry on an atomic scale. Such sophistication could accelerate the sustainable deployment of lithium–sulfur batteries within electric vehicles, grid storage, and portable electronics.

Moreover, the study emphasizes the profound impact of molecular-level phenomena on macroscopic performance metrics such as charging speed and energy density. By showing that the electrochemical environment at the nanoscale directly modulates reaction kinetics and phase evolution, this research bridges a critical knowledge gap between fundamental science and technological application. It highlights the necessity for integrated approaches combining real-time imaging, theoretical insight, and materials engineering.

Looking ahead, the insights gained are poised to influence material selection, electrolyte formulation, and cell architecture design. Tailoring these elements to favor desirable HCIL characteristics could lead to batteries that not only charge rapidly and store vast amounts of energy but also maintain stability over many cycles. Furthermore, the foundational principles elucidated may inspire innovations beyond lithium–sulfur systems, potentially transforming a range of emerging battery chemistries where interface complexity rules.

In conclusion, this remarkable study marks a pivotal advance in understanding and harnessing the subtleties of interfacial charge transfer within lithium–sulfur batteries. By unraveling the competitive reactions shaped by concentration gradients and molecular aggregation, it charts a pathway toward high-performance batteries ready for real-world demands. As energy storage solutions continue to underpin the clean energy transition, such elegant fusion of fundamental science and engineering innovation will be indispensable for propelling next-generation technologies.

Subject of Research: Charge transfer and reaction mechanisms at solid–liquid interfaces in lithium–sulfur batteries.

Article Title: Revealing competitive interfacial reactions in high-energy Li–S batteries.

Article References:
Zhou, S., Pei, F., Zheng, Q. et al. Revealing competitive interfacial reactions in high-energy Li–S batteries. Nature (2026). https://doi.org/10.1038/s41586-025-09473-2

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41586-025-09473-2